Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2018 Filed Feb 28, 2018 14:22 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 6,459 | $169.00 | $1,091,571.00 |
DisclosureSEC source: 0001209191-18-014340 · doc4.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,752 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 14:22 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionCommon Stock | 1,554 | $86.52 | $134,452.08 |
DisclosureSEC source: 0001209191-18-014340 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,211 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 14:30 UTC |
Sachdev AmitEVP, CRO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,155 | $0.00 Strike: $91.05 | $0.00 |
DisclosureSEC source: 0001209191-18-014341 · doc4.xml · derivative · entry 5 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,242 Underlying: Common Stock · 2,155 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 2/2/2016. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 14:30 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 2,155 | $170.00 | $366,350.00 |
DisclosureSEC source: 0001209191-18-014341 · doc4.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,662 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 14:30 UTC |
Sachdev AmitEVP, CRO
|
Exercise / conversionCommon Stock | 2,155 | $91.05 | $196,212.75 |
DisclosureSEC source: 0001209191-18-014341 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 23:16 UTC |
Silva Paul MSVP & Corp Controller
|
SaleCommon Stock | 3,437 | $158.49 | $544,730.13 |
DisclosureSEC source: 0001209191-18-012084 · doc4.xml · nonDerivative · entry 1 Silva Paul M · CIK 0001446372 · SVP & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,525 F1 · kind: Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:23 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 2,022 | $152.26 | $307,869.72 |
DisclosureSEC source: 0001209191-18-010396 · doc4.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,657 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:23 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 2,022 | $151.40 | $306,130.80 |
DisclosureSEC source: 0001209191-18-010396 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,679 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 22:23 UTC |
Silva Paul MSVP & Corp Controller
|
SaleCommon Stock | 4,213 | $153.41 | $646,316.33 |
DisclosureSEC source: 0001209191-18-010005 · doc4.xml · nonDerivative · entry 1 Silva Paul M · CIK 0001446372 · SVP & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,962 F1 · kind: Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 22:39 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 12,136 | $153.41 | $1,861,783.76 |
DisclosureSEC source: 0001209191-18-010038 · doc4.xml · nonDerivative · entry 1 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,998 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 22:53 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 100 | $153.84 | $15,384.00 |
DisclosureSEC source: 0001209191-18-010068 · doc4.xml · nonDerivative · entry 5 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,999 F1 · kind: Transaction made pursuant to Mr. Altshuler's company-approved trading plan under Rule 10b5-1. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 22:53 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 700 | $153.11 | $107,177.00 |
DisclosureSEC source: 0001209191-18-010068 · doc4.xml · nonDerivative · entry 4 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,099 F1 · kind: Transaction made pursuant to Mr. Altshuler's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $153.11 (range $152.71 to $153.59). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 22:53 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 1,953 | $151.40 | $295,684.20 |
DisclosureSEC source: 0001209191-18-010068 · doc4.xml · nonDerivative · entry 3 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,799 F1 · kind: Transaction made pursuant to Mr. Altshuler's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $151.40 (range $151.02 to $151.90). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 22:53 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 1,900 | $150.67 | $286,273.00 |
DisclosureSEC source: 0001209191-18-010068 · doc4.xml · nonDerivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,752 F1 · kind: Transaction made pursuant to Mr. Altshuler's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $150.67 (range $150.01 to $150.97). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 22:53 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 1,750 | $149.23 | $261,152.50 |
DisclosureSEC source: 0001209191-18-010068 · doc4.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,652 F1 · kind: Transaction made pursuant to Mr. Altshuler's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $149.23 (range $148.77 to $149.74). F3 · price: Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:15 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 300 | $153.69 | $46,107.00 |
DisclosureSEC source: 0001209191-18-010119 · doc4.xml · nonDerivative · entry 5 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,663 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $153.69 (range $153.59 to $153.90). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:15 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 400 | $152.62 | $61,048.00 |
DisclosureSEC source: 0001209191-18-010119 · doc4.xml · nonDerivative · entry 4 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,963 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $152.62 (range $152.09 to $152.96). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:15 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 2,022 | $151.26 | $305,847.72 |
DisclosureSEC source: 0001209191-18-010119 · doc4.xml · nonDerivative · entry 3 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,363 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $151.26 (range $150.88 to $151.86). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:15 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 1,100 | $150.47 | $165,517.00 |
DisclosureSEC source: 0001209191-18-010119 · doc4.xml · nonDerivative · entry 2 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,385 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $150.47 (range $149.83 to $150.76). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:15 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 1,300 | $149.21 | $193,973.00 |
DisclosureSEC source: 0001209191-18-010119 · doc4.xml · nonDerivative · entry 1 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,485 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $149.21 (range $148.80 to $149.64). F3 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:06 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 200 | $153.89 | $30,778.00 |
DisclosureSEC source: 0001209191-18-010105 · doc4.xml · nonDerivative · entry 6 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,658 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F8 · price: Open market sales reported on this line occurred at a weighted average price of $153.89 (range $153.88 to $153.89). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:06 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 2,000 | $153.29 | $306,580.00 |
DisclosureSEC source: 0001209191-18-010105 · doc4.xml · nonDerivative · entry 5 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,858 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $153.29 (range $152.88 to $153.84). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:06 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 1,200 | $152.40 | $182,880.00 |
DisclosureSEC source: 0001209191-18-010105 · doc4.xml · nonDerivative · entry 4 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,858 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $152.40 (range $151.85 to $152.81). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:06 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 10,100 | $151.23 | $1,527,423.00 |
DisclosureSEC source: 0001209191-18-010105 · doc4.xml · nonDerivative · entry 3 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,058 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $151.23 (range $150.83 to $151.82). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:06 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 4,305 | $150.44 | $647,644.20 |
DisclosureSEC source: 0001209191-18-010105 · doc4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,158 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $150.44 (range $149.79 to $150.76). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:06 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 6,100 | $149.22 | $910,242.00 |
DisclosureSEC source: 0001209191-18-010105 · doc4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,463 F1 · kind: Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $149.22 (range $148.77 to $149.74). F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:16 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 1,270 | $153.80 | $195,326.00 |
DisclosureSEC source: 0001209191-18-010129 · doc4.xml · nonDerivative · entry 4 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,701 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1. F2 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $153.80 (range $153.67 to $153.99). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:16 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 3,879 | $153.07 | $593,758.53 |
DisclosureSEC source: 0001209191-18-010129 · doc4.xml · nonDerivative · entry 3 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,971 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1. F2 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $153.07 (range $152.67 to $153.66). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:16 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 800 | $152.27 | $121,816.00 |
DisclosureSEC source: 0001209191-18-010129 · doc4.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,850 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1. F2 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $152.27 (range $151.67 to $152.62). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:16 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 875 | $150.78 | $131,932.50 |
DisclosureSEC source: 0001209191-18-010129 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,650 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1. F2 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $150.78 (range $150.42 to $151.20). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:23 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 300 | $153.92 | $46,176.00 |
DisclosureSEC source: 0001209191-18-010146 · doc4.xml · nonDerivative · entry 6 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,662 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F8 · price: Open market sales reported on this line occurred at a weighted average price of $153.92 (range $153.89 to $153.99). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:23 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 1,400 | $153.25 | $214,550.00 |
DisclosureSEC source: 0001209191-18-010146 · doc4.xml · nonDerivative · entry 5 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,962 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $153.25 (range $152.87 to $153.82). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:23 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 1,100 | $152.26 | $167,486.00 |
DisclosureSEC source: 0001209191-18-010146 · doc4.xml · nonDerivative · entry 4 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,362 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $152.26 (range $151.83 to $152.81). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:23 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 7,296 | $151.22 | $1,103,301.12 |
DisclosureSEC source: 0001209191-18-010146 · doc4.xml · nonDerivative · entry 3 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,462 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $151.22 (range $150.81 to $151.79). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:23 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 3,200 | $150.44 | $481,408.00 |
DisclosureSEC source: 0001209191-18-010146 · doc4.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,758 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $150.44 (range $149.81 to $150.76). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:23 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 4,500 | $149.22 | $671,490.00 |
DisclosureSEC source: 0001209191-18-010146 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,958 F1 · kind: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $149.22 (range $148.77 to $149.75). F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 22:49 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
GrantStock Option (Right to Buy) · Derivative | 23,479 | $0.00 Strike: $155.57 | $0.00 |
DisclosureSEC source: 0001209191-18-008515 · doc4.xml · derivative · entry 3 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,479 Underlying: Common Stock · 23,479 shares Expires 2028-02-05 F3 · derivative.exercise_date: This option vests in 16 quarterly installments from 2/6/2018. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 22:49 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
GrantCommon Stock | 10,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-008515 · doc4.xml · nonDerivative · entry 2 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,785 F2 · shares: Restricted stock unit award that vests in three equal installments on 2/17/2019, 2/17/2020 and 2/17/2021. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 22:49 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
GrantCommon Stock | 12,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-008515 · doc4.xml · nonDerivative · entry 1 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,660 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 2/3/2017 that contained both performance-vesting and service-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 2/6/2018. The earned performance shares remain subject to the service-vesting requirements and will vest in three equal installments on 2/10/2018, 2/10/2019 and 2/10/2020. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 22:53 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 19,566 | $0.00 Strike: $155.57 | $0.00 |
DisclosureSEC source: 0001209191-18-008518 · doc4.xml · derivative · entry 4 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,566 Underlying: Common Stock · 19,566 shares Expires 2028-02-05 F3 · derivative.exercise_date: The option vests in 16 quarterly installments from 2/6/2018. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 22:53 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
GrantCommon Stock | 8,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-008518 · doc4.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,525 F2 · shares: Restricted stock unit award that vests in three equal installments on 2/17/2019, 2/17/2020 and 2/17/2021. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 22:53 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
GrantCommon Stock | 12,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-008518 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,088 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 2/3/2017 that contained both performance-vesting and service-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 2/6/2018. The earned performance shares remain subject to the service-vesting requirements and will vest in three equal installments on 2/10/2018, 2/10/2019 and 2/10/2020. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 22:58 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
GrantStock Option (Right to Buy) · Derivative | 19,566 | $0.00 Strike: $155.57 | $0.00 |
DisclosureSEC source: 0001209191-18-008519 · doc4.xml · derivative · entry 3 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,566 Underlying: Common Stock · 19,566 shares Expires 2028-02-05 F3 · derivative.exercise_date: The option vests in 16 quarterly installments from 2/6/2018. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 22:58 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
GrantCommon Stock | 8,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-008519 · doc4.xml · nonDerivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,402 F2 · shares: Restricted stock unit award that vests in three equal installments on 2/17/2019, 2/17/2020 and 2/17/2021. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 22:58 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
GrantCommon Stock | 18,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-008519 · doc4.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,965 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 2/03/2017 that contained both performance-vesting and service-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 2/6/2018. The earned performance shares remain subject to the service-vesting requirements and will vest in three equal installments on 2/10/2018, 2/10/2019 and 2/10/2020. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 23:07 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
GrantStock Option (Right to Buy) · Derivative | 73,046 | $0.00 Strike: $155.57 | $0.00 |
DisclosureSEC source: 0001209191-18-008526 · doc4.xml · derivative · entry 4 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,046 Underlying: Common Stock · 73,046 shares Expires 2028-02-05 F3 · derivative.exercise_date: This option vests in 16 quarterly installments from 2/6/2018. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 23:07 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
GrantCommon Stock | 31,498 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-008526 · doc4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,563 F2 · shares: Restricted stock unit award that vests in three equal installments on 2/17/2019, 2/17/2020 and 2/17/2021. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 23:07 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
GrantCommon Stock | 50,568 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-008526 · doc4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,065 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 2/03/2017 that contained both performance-vesting and service-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2018. The earned performance shares remain subject to the service-vesting requirements and will vest in three equal installments on 2/10/2018, 2/10/2019 and 2/10/2020. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 23:10 UTC |
Sachdev AmitEVP, CRO
|
GrantStock Option (Right to Buy) · Derivative | 23,479 | $0.00 Strike: $155.57 | $0.00 |
DisclosureSEC source: 0001209191-18-008531 · doc4.xml · derivative · entry 5 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,479 Underlying: Common Stock · 23,479 shares Expires 2028-02-05 F3 · derivative.exercise_date: This option vests in 16 quarterly installments from 2/6/2018. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 23:10 UTC |
Sachdev AmitEVP, CRO
|
GrantCommon Stock | 10,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-008531 · doc4.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,458 F2 · shares: Restricted stock unit award that vests in three equal installments on 2/17/2019, 2/17/2020 and 2/17/2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.